TRANSLATING INNOVATIVE SCIENCE
Into Novel Lupus Therapeutics
Resolve Therapeutics is a private biotechnology company that is dedicated to the goal of improving the lives of patients suffering from lupus.
Resolve Announces Positive Clinical Data from RSLV-132 Lupus Study
Resolve Initiates RSLV-132 Clinical Studies
A Proof-of-Concept for Fast Exit Strategy
Resolve Corporate Overview
© 2016 Resolve Therapeutics